Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in Pharvaris N.V. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +15 vs. Q3 2023
- Shares held
- 40.7M
- +11.7M (+40.2%) vs. Q3 2023
- Total value
- $1.14B
- +$536.3M (+88.4%) vs. Q3 2023
- New holders
- 18
- 12 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 125 | $2.23B |
| Q1 2026 | 110 | $1.67B |
| Q4 2025 | 106 | $1.64B |
| Q3 2025 | 83 | $1.44B |
| Q2 2025 | 60 | $792.7M |
| Q1 2025 | 52 | $705.5M |
| Q4 2024 | 54 | $855.8M |
| Q3 2024 | 51 | $834.2M |
| Q2 2024 | 36 | $808.6M |
| Q1 2024 | 35 | $980.5M |
| Q4 2023 | 36 | $1.14B |
| Q3 2023 | 21 | $606.6M |
| Q2 2023 | 21 | $441.6M |
| Q1 2023 | 21 | $173.9M |
| Q4 2022 | 25 | $239.6M |
| Q3 2022 | 21 | $173.6M |
| Q2 2022 | 20 | $494.0M |
| Q1 2022 | 22 | $397.1M |
| Q4 2021 | 22 | $321.1M |
| Q3 2021 | 25 | $380.3M |
| Q2 2021 | 28 | $406.3M |
| Q1 2021 | 33 | $616.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| General Atlantic LLC | 6,156,252 | $172.7M | 2.48% | +1,750,000+39.7% | Added |
| FMR LLC | 5,192,984 | $145.7M | 0.01% | +1,985,420+61.9% | Added |
| venBio Partners LLC | 4,919,504 | $138.0M | 20.68% | +654,832+15.4% | Added |
| Foresite Capital Management IV, LLC | 4,038,842 | $113.3M | 57.25% | +295,392+7.9% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,904,319 | $109.5M | 10.50% | −880,355−18.4% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,656,923 | $102.6M | 0.38% | +425,000+13.2% | Added |
| VR Adviser, LLC | 3,395,606 | $95.2M | 6.53% | +1,832,093+117.2% | Added |
| Cormorant Asset Management, LP | 1,711,460 | $48.0M | 2.30% | +350,000+25.7% | Added |
| Novo Holdings A/S | 1,539,325 | $43.2M | 2.89% | +210,000+15.8% | Added |
| EcoR1 Capital, LLC | 900,000 | $25.2M | 0.66% | +900,000 | New |
| Price T Rowe Associates Inc | 842,698 | $23.6M | 0.00% | +842,698 | New |
| Deerfield Management Company, L.P. (Series C) | 812,236 | $22.8M | 0.42% | +812,236 | New |
| Commodore Capital LP | 800,000 | $22.4M | 1.96% | +800,000 | New |
| 5AM Venture Management, LLC | 797,600 | $22.4M | 5.93% | +210,000+35.7% | Added |
| Sofinnova Investments, Inc. | 510,441 | $14.3M | 0.80% | +510,441 | New |
| Vivo Capital, LLC | 285,000 | $7.99M | 0.65% | +285,000 | New |
| Sphera Funds Management Ltd. | 245,000 | $6.87M | 1.28% | +245,000 | New |
| Soleus Capital Management, L.P. | 217,396 | $6.10M | 0.68% | −126,579−36.8% | Reduced |
| Millennium Management LLC | 188,516 | $5.29M | 0.01% | +188,516 | New |
| Citadel Advisors LLC | 141,458 | $3.97M | 0.00% | +141,458 | New |
| Blackstone Group Inc. | 100,000 | $2.81M | 0.01% | +100,000 | New |
| Walleye Capital LLC | 77,870 | $2.18M | 0.03% | −3,147−3.9% | Reduced |
| Hudson Bay Capital Management LP | 70,134 | $1.97M | 0.02% | +31,241+80.3% | Added |
| Marshall Wace, LLP | 60,124 | $1.69M | 0.00% | +60,124 | New |
| Manufacturers Life Insurance Company, The | 55,078 | $1.54M | 0.00% | +55,078 | New |
| Qube Research & Technologies Ltd | 32,318 | $906.5K | 0.00% | +29,739+1,153.1% | Added |
| Morgan Stanley | 22,488 | $630.8K | 0.00% | −11,209−33.3% | Reduced |
| Geode Capital Management, LLC | 21,595 | $605.7K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 18,000 | $504.9K | 0.02% | +18,000 | New |
| Schonfeld Strategic Advisors LLC | 12,400 | $347.8K | 0.00% | +500+4.2% | Added |
| Goldman Sachs Group Inc | 8,549 | $239.8K | 0.00% | +8,549 | New |
| Two Sigma Investments, LP | 8,198 | $230.0K | 0.00% | +8,198 | New |
| BlackRock Inc. | 2,268 | $63.6K | 0.00% | 00.0% | Unchanged |
| Quarry LP | 750 | $21.0K | 0.01% | +750 | New |
| JPMorgan Chase & Co | 190 | $5.33K | 0.00% | +190 | New |
| Piper Sandler & Co. | 181 | $5.08K | 0.00% | +181 | New |
| Foresite Capital Management V, LLC | 0 | $0 | 0.00% | −33,142−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −17,553−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −50−100.0% | Sold out |